ISTH 2022 Congress
July 9-13, 2022. London, England, UK.
- Acquired Bleeding Disorders (75)
- Arterial Thromboembolism (75)
- Coagulation and Natural Anticoagulants (138)
- COVID and Coagulation (172)
- Diagnostics and OMICs (110)
- Fibrinolysis and Proteolysis (45)
- Hemophilia and Rare Bleeding Disorders (297)
- Hemostatic Systems in Cancer, Inflammation and Immunity (76)
- Nurses and Allied Health (4)
- Pediatrics (74)
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies (216)
- Acquired Thrombocytopenias (34)
- ADAMTS13 and TTP (35)
- Antiplatelet Therapy (9)
- Blood Cells and Vessel Wall (36)
- Endothelial Cell Signaling (12)
- HIT (13)
- HUS (4)
- Inherited Thrombocytopenias (15)
- Non-coding RNAs (3)
- Non HUS/TTP Microangiopathies (2)
- Platelet Antagonists and Novel Therapeutics (9)
- Platelet Function Disorders, Acquired (7)
- Platelet Function Disorders, Hereditary (20)
- von Willebrand Factor Biology (21)
- VWF and von Willebrand Factor Disorders - Clinical Conditions (43)
- Platelets and Megakaryocytes (164)
- Vascular Biology (74)
- Venous Thromboembolism (299)
- Women’s Health (57)